Mechanism of Hoechst 33342-induced apoptosis in BC3H-1 myocytes

Annals of Clinical and Laboratory Science

Volumn 28, Issue 2, 1998, Pages 104-114

  Zhang, Xinbo ^a   Kiechle, Frederick L ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYCLOHEXIMIDE; CYSTEINE PROTEINASE; DACTINOMYCIN; DNA; DNA TOPOISOMERASE; HOE 33342; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; LACTIC ACID; PIBENZIMOL; PROTEIN P53; PROTEINASE INHIBITOR; SERINE PROTEINASE; THYMINE; TOSYLLYSYL CHLOROMETHYL KETONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MITOCHONDRION; MOUSE; MUSCLE CELL; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RNA SYNTHESIS;

ANIMALS; APOPTOSIS; BENZIMIDAZOLES; CELL LINE; CYCLOHEXIMIDE; DACTINOMYCIN; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; GENE EXPRESSION; GENES, P53; MICE; MUSCLES; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS;

ANIMALIA;

EID: 0031979362     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Zhang X, Kiechle FL. Hoechst 33342-induced apoptosis in BC3H-1 myocytes. Ann Clin Lab Sci 1997;27: 260-75.
2. Sen S, D'Incalci M. Apoptosis: biochemical events and relevance to cancer chemotherapy. FEBS Lett 1992;307:122-7.
3. Sun XM, Snowden RT, Dinsdale D, Ormerod MG, Cohen GM. Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide. Biochem Pharmacol 1994;47: 187-95.
4. Suzuki A, Kato M. Chemotherapeutic agent CPT-11 induces the new expression of the apoptosis initiator to the cytoplasm. Exp Cell Res 1996;227:154-9.
5. Sellins KS, Cohen JJ. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987;139:3199-206.
6. Wertz IE, Hanley MR. Diverse molecular provocation of programmed cell death. TIBS 1996;21:359-64.
7. Ashkenas J, Werb Z. Proteolysis and the biochemistry of life-or-death decision. J Exp Med 1996;183:1947-51.
8. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
9. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
10. Levine AJ, P53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
11. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16.
12. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993;75:641-52.
13. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993;75:653-60.
14. Gagliardini V, Fernandez PA, Lee RK, et al. Prevention of vertebrate neuronal death by the crm A gene. Science 1994;263:826-8.
15. Tewari M, Dixit VM. Fas- and tumor necrosis factorinduced apoptosis is inhibited by the poxvirus crm A gene product. J Biol Chem 1995;270:3255-60.
16. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
17. Harper JW, Adami GR, Wei N, Keyomarsi K, Ellegde SJ. The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75:805-16.
18. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
19. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993;362:849-52.
20. Lowe SW, Schnmitt EM, Smith SW, Osborne BA, Jacks T. P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993;362:847-9.
21. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
22. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142:67-77.
23. Shi Y, Szalay MG, Paskar L, et al. Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. J Immunol 1990;144:3326-33.
24. Jacobson MD, Burne JF, Raff MC. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 1994;13:1899-910.
25. Susin SA, Zamzami N, Castedo M, et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/ APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 1997;186:25-37.
26. Zamzami N, Susin SA, Marchetti P, et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996; 183:1533-44.
27. Adjei PN, Kaufmann SH, Leung WY, Mao F, Gores GJ. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a proteasedependent pathway that does not activate cysteine protease P32. J Clin Invest 1996;98:2588-96.
28. Froelich-Ammon SJ, Osheroff N. Topoisomerase poisons: harnessing the dark side of enzyme mechanisms. J Biol Chem 1995;270:21429-32.
29. Liu LF, Duann P, Lin CT, D'Arpa P, Wu J. Mechanism of action of camptothecin. Ann NY Acad Sci 1996;803:44-9.
30. Lavergne O, Lesueur-Ginot L, Rodas FP, Bigg DCH. BN 80245: an E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activities. Bioorganic Med Chem Lett 1997;7:2235-8.
31. Sim S-P, Gatto B, Yu C, et al. Differential poisoning of topoisomerases by menogaril and nogalamycin dictated by the minor groove-binding nogalose sugar. Biochemistry 1997;36:13285-91.
32. Shimizu T, Pommier Y. Camptothecin-induced apoptosis in p53-null leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases. Leukemia 1997; 11:1238-44.
33. Gilbert DE, Feigon J. Structural analysis of drug-DNA interactions. Curr Opin Struct Biol 1991;1:439-45.
34. Neidle S, Pearl LH, Skelly JV. DNA structure and perturbation by drug binding. Biochem J 1987;243:1-13.
35. Chen AY, Yu C, Gatto B, Lui LF. DNA minor groovebinding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc Natl Acad Sci USA 1993;90:8131-5.
36. Beerman TA, McHugh MM, Sigmund R, Lown JW, Rao KE, Bathini Y. Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities. Biochim Biophys Acta 1992;1131:53-61.
37. Chiang SY, Welch J, Rauscher FJ III, Beerman TA. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA. Biochemistry 1994;33:7033-40.
38. Ofenstein JP, Dandurand DM, Kiechle FL. Assessment of mitochondrial function in cells grown in tissue culture. Ann Clin Lab Sci 1992;22:406-13.
39. Guilhot S, Miller T, Cornman G, Isom HC. Apoptosis induced by tumor necrosis factor-α in rat hepatocyte cell lines expressing hepatitis B virus. Am J Pathol 1996;148:801-14.
40. Ofenstein JP, Kiechle FL, Dandurand DM, Belknap WM, Moore KH, Holmes RD. Lactate oxidation for the detection of mitochondrial dysfunction in human skin fibroblasts. Anal Biochem 1993;210:332-6.
41. Tanizawa A, Pommier Y. Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture. Cancer Res 1992; 52:1848-54.
42. Frydman B, Marton LJ, Sun JS, et al. Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones. Cancer Res 1997;57:620-7.
43. Liebennann DA, Hoffman B, Steinman RA. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 1995;11:199-210.
44. Bellamy CO, Clarke AR, Wyllie AH, Harrison DJ. P53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J 1997;11:591-9.
45. Li CJ, Wang C, Pardee AB. Induction of apoptosis by β-lapachone in human prostate cancer cells. Cancer Res 1995;55:3712-5.
46. Planchon SM, Wuerzberger S, Frydman B, et al. β-la-pachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response. Cancer Res 1995;55: 3706-11.
47. Khaoustov VI, Ozer A, Smith JR, et al. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin. Lab Invest 1995;73:118-27.
48. Oren M. Lonely no more: p53 finds its kin in a tumor suppressor haven. Cell 1997;90:829-32.
49. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis. and its inhibitor ICAD. Nature 1998;391:43-50.
50. Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G. Implication of mitochondrial hydrogen peroxide generation in ceramide-iuduced apoptosis. J Biol Chem 1997;272:21388-95.
51. Morris EJ, Geller HM. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J Cell Biol 1996;134:757-70.